SCHEMBL11037569

SCHEMBL11037569

COC(OC)C(C#N)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.46
TRPA1 O75762 1/20 0.43
TSHR P16473 1/20 0.43
MAP2K1 Q02750 1/20 0.41
ESR1 P03372 4/20 0.39
ESR2 Q92731 4/20 0.39
ALDH1A1 P00352 3/20 0.38
PBRM1 Q86U86 1/20 0.38
KMT2A Q03164 1/20 0.35
EPHX1 P07099 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C1 Q04828 1/20 0.34
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL819626 0.79 ESR1 (0.56) TRPA1TSHRMAP2K1ESR1ESR2
SCHEMBL6309534 0.79 ESR1 (0.56) TRPA1TSHRMAP2K1ESR1ESR2
SCHEMBL11206959 0.79 L3MBTL1 (0.41) TRPA1TSHRMAP2K1ESR1ESR2
SCHEMBL27946333 0.77 TRPA1 (0.56) THRBTRPA1TSHRMAP2K1ESR1
SCHEMBL955278 0.76 TRPA1 (0.48) TRPA1TSHRMAP2K1ESR1ESR2
SCHEMBL198465 0.74 TSHR (0.46) THRBTRPA1TSHRALDH1A1PBRM1
Hydrochloric Acid SCHEMBL5299628 0.74 TRPA1 (0.46) TRPA1TSHRMAP2K1ESR1ESR2
SCHEMBL198464 0.74 TSHR (0.46) THRBTRPA1TSHRALDH1A1PBRM1
SCHEMBL1343606 0.74 ESR1 (0.64) TRPA1TSHRMAP2K1ESR1ESR2
SCHEMBL27625768 0.74 TSHR (0.46) THRBTRPA1TSHRALDH1A1PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140187545-A1 Pyrazolopyrimidine Derivatives As PI3 Kinase Inhibitors GLAXOSMITHKLINE LLC (US) 2014-07-03 US disclosed
US-4438041-A FROM A CYANOACETALDEHYDE ACETAL, HYDROXYLAMINE, AND AN ALCOHOL UBE INDUSTRIES, LTD. (JP) 1984-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140187545-A1 Pyrazolopyrimidine Derivatives As PI3 Kinase Inhibitors PI4KB, PIK3CA, PI4K2B THRB 797/4885TRPA1 4690/4885TSHR 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.